Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

CME Group stock

CME
US12572Q1058
A0MW32

Price

220.49
Today +/-
-4.30
Today %
-2.11 %
P

CME Group stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the CME Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the CME Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the CME Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze CME Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

CME Group Stock Price History

DateCME Group Price
11/6/2024220.49 undefined
11/5/2024225.19 undefined
11/4/2024223.08 undefined
11/1/2024223.61 undefined
10/31/2024225.36 undefined
10/30/2024227.26 undefined
10/29/2024227.09 undefined
10/28/2024228.12 undefined
10/25/2024226.14 undefined
10/24/2024229.69 undefined
10/23/2024227.14 undefined
10/22/2024226.17 undefined
10/21/2024227.05 undefined
10/18/2024228.32 undefined
10/17/2024227.23 undefined
10/16/2024227.17 undefined
10/15/2024224.82 undefined
10/14/2024224.20 undefined
10/11/2024221.72 undefined
10/10/2024221.25 undefined
10/9/2024221.46 undefined
10/8/2024221.68 undefined

CME Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into CME Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by CME Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects CME Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of CME Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into CME Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing CME Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on CME Group’s growth potential.

CME Group Revenue, EBIT and net profit per share

DateCME Group RevenueCME Group EBITCME Group Net Income
2028e6.9 B undefined4.87 B undefined4.13 B undefined
2027e6.63 B undefined4.67 B undefined3.95 B undefined
2026e6.61 B undefined4.36 B undefined3.93 B undefined
2025e6.33 B undefined4.19 B undefined3.76 B undefined
2024e6.18 B undefined4.1 B undefined3.71 B undefined
202310.85 B undefined8.71 B undefined3.19 B undefined
20227.22 B undefined5.21 B undefined2.66 B undefined
20215 B undefined2.95 B undefined2.62 B undefined
20205.07 B undefined2.82 B undefined2.11 B undefined
20195.51 B undefined3.23 B undefined2.12 B undefined
20184.31 B undefined2.61 B undefined1.96 B undefined
20173.64 B undefined2.31 B undefined4.06 B undefined
20163.6 B undefined2.2 B undefined1.53 B undefined
20153.33 B undefined1.99 B undefined1.25 B undefined
20143.11 B undefined1.77 B undefined1.13 B undefined
20132.94 B undefined1.64 B undefined976.8 M undefined
20122.91 B undefined1.69 B undefined896.3 M undefined
20113.28 B undefined2.02 B undefined1.81 B undefined
20103 B undefined1.83 B undefined951.4 M undefined
20092.61 B undefined1.59 B undefined825.8 M undefined
20082.56 B undefined1.59 B undefined715.49 M undefined
20071.76 B undefined1.06 B undefined658.53 M undefined
20061.09 B undefined621.5 M undefined407.3 M undefined
2005889.8 M undefined477.9 M undefined306.9 M undefined
2004721.6 M undefined355.4 M undefined219.6 M undefined

CME Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
0.180.20.210.230.40.470.540.720.891.091.762.562.6133.282.912.943.113.333.63.644.315.515.0757.2210.856.186.336.616.636.9
-11.306.607.6275.2218.4315.9932.5423.3022.5061.2545.841.9914.979.22-11.160.755.996.888.091.3618.2527.76-7.97-1.3844.4650.39-43.082.444.440.264.10
100.00100.00100.00100.0097.7396.5998.53-------------------------
1771972102263874535360000000000000000000000000
0.020.010.01-0.020.130.160.210.360.480.621.061.591.591.832.021.691.641.771.992.22.312.613.232.822.955.218.714.14.194.364.674.87
10.737.112.86-6.6431.5734.1237.8749.2453.6657.0260.3661.9761.0360.9461.6258.0655.7656.8159.7761.2063.3960.5058.5855.6759.0972.2580.2666.4366.2365.9970.3970.59
0.010.010-0.010.080.090.120.220.310.410.660.720.830.951.810.90.981.131.251.534.061.962.122.112.622.663.193.713.763.933.954.13
--12.50-71.43-600.00-850.0025.3329.7979.5139.7333.0161.678.6615.3815.2790.54-50.558.9315.4710.6523.02164.86-51.717.85-0.5224.321.5319.8716.581.354.330.514.59
--------------------------------
--------------------------------
159.1159.09159.09143.87146.2150.3169.7172.1174.2175.6220.54294.84332.7332.5333.8332.3334.4336.1337.9339340.2343.7358.2358.5358.9359.2359.500000
--------------------------------
Details

Keystats

Revenue and Growth

The CME Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the CME Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                               
0.070.160.340.810.750.91.241.050.610.30.911.091.662.541.441.771.951.991.451.631.732.952.823.02
28.5340.9950.8752.9778.8384.97127.2187.49234248.3297.5289.4267.5302.7341.2357.8364.4359.7553.3491.8461.3434.5483.2535.6
0000004.522.6633.527.311.80000000000000
000000000000000000000000
0.161.742.833.861.872.792.683.7518.246.124.179.576.7921.5640.7635.7837.7244.5539.8937.4487.09158.38135.7891.33
0.271.953.224.722.73.784.054.9919.116.75.3910.958.7224.4142.5537.940.0346.9141.8939.5789.28161.76139.0894.89
0.080.10.110.120.130.150.170.380.710.740.790.820.720.510.510.490.430.40.451.061.060.930.840.74
0000000.010.020.350.370.34000.99100.9911.031.021.022.442.762.77
000000000000000000000000
0000000.019.7820.3620.2420.520.3620.0319.9219.8119.7119.6219.5222.6822.2922.0420.7120.4520.23
0000000.015.057.527.557.987.987.577.577.577.577.577.5710.8110.7410.810.5310.4810.5
0.030.020.030.030.030.030.050.080.110.060.040.651.830.880.811.680.730.40.630.530.460.410.570.59
0.110.120.140.150.160.190.2615.3229.0528.9529.6629.8130.1529.8729.729.4529.3428.8835.5935.6535.3835.0235.134.82
0.382.073.364.872.863.974.3120.3148.1635.6535.0540.7638.8654.2872.2467.3669.3775.7977.4875.22124.66196.78174.18129.71
                                               
0.290.290.330.330.340.350.350.530.70.70.73.33.33.33.43.43.43.43.63.63.63.63.63.6
0.040.060.180.20.260.320.4110.6917.1317.1917.2817.1117.2117.517.617.7217.8317.921.0521.1121.1922.1922.2622.33
0.120.190.270.370.550.81.121.621.722.242.894.323.993.493.322.912.524.54.865.0155.154.754.46
-0.01-1.18-0.67-0.87-1.6-2.91-2.98-3.1-160.3-126.6-109.8111.6-47.453.129.114.25.413.75.22.6133.352.4-132.4-55.2
0000000000.45.70256.798.9-22.9-95-19.50.60.10.81.61.1-0.9-0.4
0.160.250.450.560.811.121.5212.3118.6919.320.0621.5521.4221.1520.9220.5520.3422.4125.9226.1326.3227.426.8826.74
11.923.8327.6124.6923.0523.5525.5558.977146.751.831.141.736.236.928.726.231.311661.969.348.8121.490.6
00000061.1118.31143.499.4141.20000000042.344.547.349.946.7
0.191.782.864.2622.812.673.7318.186.084.179.586.8322.5241.4936.838.9245.6440.5838.4188.08159.55137.4993.27
000000000000000000000000
0000000164.44249.9299.8420.50749.7749.90000574.27.47.7757.324.28.4
0.21.82.894.292.032.832.764.0818.646.524.789.627.6223.3141.5336.8238.9545.6741.2738.5288.2160.4137.6993.42
0.010.010000002.972.012.12.112.112.112.112.232.232.233.833.833.532.773.493.48
00000003.857.737.657.847.237.417.257.37.367.294.865.675.645.615.395.365.33
0.010.010.020.020.020.020.030.080.130.170.190.190.220.450.380.40.560.620.751.060.980.820.760.74
0.020.020.020.020.020.020.033.9210.839.8310.149.529.749.819.799.9810.087.7110.2410.5310.118.989.619.55
0.221.822.914.312.042.852.79829.4716.3514.9219.1417.3633.1251.3246.8149.0353.3851.5149.0698.31169.38147.3102.97
0.382.073.364.872.863.974.3120.3148.1635.6534.9840.6938.7854.2772.2467.3669.3775.7977.4375.18124.63196.78174.18129.71
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of CME Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand CME Group's financial health and stability.

Assets

CME Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that CME Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of CME Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into CME Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0-0.010.080.090.120.220.310.410.660.720.830.951.810.910.981.131.251.534.061.962.122.112.642.693.23
2533374853536574139236251258260253238233228225208248473464385362352
5-1-4-534-3-24-50-115-5622-65882-67863-83-2,445114-3-4134-23-75
-4-1600-17-39-94-34-3143-142-9-9-193-14913-10561-2267-157-53-60
2135413151824624331281241234813310118610888149183214-42216393
0000020022190104111110133111898484108146133133133129
0-0.010.050.060.080.080.170.240.410.670.630.770.820.620.610.640.720.710.760.580.590.650.760.971.11
0.030.030.120.140.190.280.350.470.811.21.081.361.351.221.281.291.521.731.752.442.672.722.43.063.45
-55-25-30-56-63-72-86-90-166-200-157-160-172-141-125-140-114-91-81-116-245-197-127-89-76
-29-12-7834-327-125-82-85-78-3,749544-111-153-208190-1991753179-1,889-152-17558-48920
2612-4790-264-534488-3,5487024818-67316-58132145261-1,7729322185-40097
0000000000000000000000000
-0-0-0-0.01-0.01-0000.161.60.490.21-0.420.75-0-0.750.070.1301.12-0.66-0.30-0.02-0.02
00011776716-908-202-544-214227353645136110096500
-0-0-00.09-0.020.02-0.01-0.03-0.862-1.67-0.65-1.01-0.45-0.61-2.2-1.21-1.62-1.99-1.08-4.7247.2569.91-25.38-48.34
000000.050.040.040.041.22-1.85-0.600.01-0.08-00-0.02-0.03-0.06-2.3649.6671.13-22.73-45.09
000-17-20-35-63-87-151-615-305-305-372-1,224-599-1,496-1,343-1,787-1,993-2,149-1,695-2,110-2,189-2,633-3,235
00.020.040.27-0.150.170.250.36-0.12-0.55-0.040.590.190.560.87-1.10.330.17-0.05-0.53-2.249.7972.37-22.82-44.86
-24.137.890.284.8128.13203.46261.58381.31647.67997.1925.21,199.61,174.11,077.91,154.91,150.71,401.11,640.21,669.22,324.12,427.22,518.12,275.22,966.33,377.4
0000000000000000000000000

CME Group stock margins

The CME Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CME Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CME Group.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the CME Group's sales revenue. A higher gross margin percentage indicates that the CME Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the CME Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the CME Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the CME Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the CME Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the CME Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

CME Group Margin History

CME Group Gross marginCME Group Profit marginCME Group EBIT marginCME Group Profit margin
2028e0 %70.59 %59.83 %
2027e0 %70.39 %59.54 %
2026e0 %65.99 %59.41 %
2025e0 %66.23 %59.47 %
2024e0 %66.43 %60.11 %
20230 %80.25 %29.35 %
20220 %72.24 %36.81 %
20210 %59.08 %52.38 %
20200 %55.66 %41.55 %
20190 %58.59 %38.44 %
20180 %60.51 %45.53 %
20170 %63.4 %111.49 %
20160 %61.21 %42.67 %
20150 %59.78 %37.48 %
20140 %56.82 %36.21 %
20130 %55.75 %33.27 %
20120 %58.05 %30.75 %
20110 %61.61 %55.24 %
20100 %60.94 %31.67 %
20090 %61.02 %31.61 %
20080 %61.97 %27.94 %
20070 %60.41 %37.5 %
20060 %57.02 %37.37 %
20050 %53.71 %34.49 %
20040 %49.25 %30.43 %

CME Group Stock Sales Revenue, EBIT, Earnings per Share

The CME Group earnings per share therefore indicates how much revenue CME Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue CME Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates CME Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of CME Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating CME Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

CME Group Revenue, EBIT and net profit per share

DateCME Group Sales per ShareCME Group EBIT per shareCME Group Earnings per Share
2028e19.16 undefined0 undefined11.46 undefined
2027e18.4 undefined0 undefined10.96 undefined
2026e18.36 undefined0 undefined10.91 undefined
2025e17.58 undefined0 undefined10.45 undefined
2024e17.16 undefined0 undefined10.31 undefined
202330.19 undefined24.23 undefined8.86 undefined
202220.09 undefined14.52 undefined7.4 undefined
202113.92 undefined8.23 undefined7.29 undefined
202014.13 undefined7.87 undefined5.87 undefined
201915.37 undefined9.01 undefined5.91 undefined
201812.54 undefined7.59 undefined5.71 undefined
201710.71 undefined6.79 undefined11.94 undefined
201610.61 undefined6.49 undefined4.53 undefined
20159.85 undefined5.89 undefined3.69 undefined
20149.26 undefined5.26 undefined3.35 undefined
20138.78 undefined4.9 undefined2.92 undefined
20128.77 undefined5.09 undefined2.7 undefined
20119.83 undefined6.05 undefined5.43 undefined
20109.03 undefined5.51 undefined2.86 undefined
20097.85 undefined4.79 undefined2.48 undefined
20088.69 undefined5.38 undefined2.43 undefined
20077.96 undefined4.81 undefined2.99 undefined
20066.21 undefined3.54 undefined2.32 undefined
20055.11 undefined2.74 undefined1.76 undefined
20044.19 undefined2.07 undefined1.28 undefined

CME Group business model

CME Group Inc, founded in 1898 as Chicago Butter and Egg Board, is an American exchange and trading platform for futures and options. It has become a global leader in derivatives trading volume. CME Group operates multiple exchange platforms specializing in various asset classes, with the most well-known being the Chicago Mercantile Exchange (CME) for financial futures and derivatives. The company's history dates back to the late 19th century when agricultural futures trading began in Chicago. It was formed by the merger of Chicago Mercantile Exchange Holdings Inc. and the Chicago Board of Trade in 2007, acquiring the New York Mercantile Exchange (NYMEX) and Kansas City Board of Trade (KCBT) in subsequent years. CME Group offers a wide range of futures and options contracts based on different asset classes, with a focus on currencies, interest rates, stock indexes, energy, and agriculture. The company operates internationally and has a strong presence in regulatory compliance. It provides clearing services to minimize counterparty risk in futures transactions. Notable products offered by CME Group include currency futures (Euro FX, Japanese Yen, Swiss Franc, British Pound Sterling), stock index futures (S&P 500, NASDAQ-100, Dow Jones Industrial Average), energy futures (oil, gas, electricity), agricultural futures (corn, soybeans, wheat), as well as newer offerings such as Bitcoin futures and Micro-E-mini Futures. CME Group's business model centers on providing a secure and transparent trading platform for hedging risks and generating capital returns. It earns revenue from fees charged for trading and clearing futures contracts. The company is highly regarded in the industry for its innovation and global market leadership. CME Group is one of the most popular companies on Eulerpool.com.

CME Group SWOT Analysis

Strengths

CME Group Inc has a leading position in the global derivatives and options market, providing a diverse range of products and services.

The strong brand recognition and reputation of CME Group Inc help in attracting customers and maintaining market share.

The company benefits from advanced technology infrastructure, enabling efficient and reliable trading operations.

Weaknesses

CME Group Inc is highly dependent on market conditions, making it vulnerable to economic downturns and fluctuations in trading volumes.

The company faces intense competition from other exchanges, which may impact its market position and pricing power.

Limited diversification of its revenue streams makes CME Group Inc susceptible to risks associated with its core business.

Opportunities

Expansion into new geographical markets, particularly emerging economies, can provide growth opportunities for CME Group Inc.

The increasing demand for risk management tools and hedging instruments creates opportunities for the company to introduce innovative products.

Strategic partnerships and acquisitions can help CME Group Inc strengthen its market position and expand its product portfolio.

Threats

Regulatory changes and government policies can impact the operations and profitability of CME Group Inc.

The emergence of new technologies and competitors in the financial services industry poses a threat to the company's market share.

Fluctuations in interest rates and currency exchange rates can affect the financial performance of CME Group Inc.

CME Group Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

CME Group Revenue by Segment

Segmente20232021202020192018
Clearing and Transaction Fees4.59 B USD3.77 B USD3.9 B USD3.95 B USD3.67 B USD
MarketData663.7 M USD576.9 M USD545.4 M USD518.5 M USD449.6 M USD
OtherRevenue326.7 M USD347.7 M USD440.8 M USD403.4 M USD192.8 M USD

CME Group Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

CME Group historical P/E ratio, EBIT multiple, and P/S ratio

CME Group shares outstanding

The number of shares was CME Group in 2023 — This indicates how many shares 359.5 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue CME Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates CME Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of CME Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating CME Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

CME Group stock splits

In CME Group's history, there have been no stock splits.

CME Group dividend history and estimates

In 2023, CME Group paid a dividend amounting to 9.65 USD. Dividend means that CME Group distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for CME Group provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify CME Group’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating CME Group's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

CME Group Dividend History

DateCME Group Dividend
2028e9.59 undefined
2027e9.6 undefined
2026e9.6 undefined
2025e9.58 undefined
2024e9.61 undefined
20239.65 undefined
20228.5 undefined
20216.85 undefined
20205.9 undefined
20195.5 undefined
20184.55 undefined
20176.14 undefined
20168.9 undefined
20154.9 undefined
20143.88 undefined
20134.4 undefined
20123.09 undefined
20111.12 undefined
20100.92 undefined
20090.92 undefined
20081.92 undefined
20070.69 undefined
20060.5 undefined
20050.37 undefined
20040.21 undefined

CME Group dividend payout ratio

In 2023, CME Group had a payout ratio of 103.11%. The payout ratio indicates the percentage of the company's profits that CME Group distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for CME Group represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for CME Group could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate CME Group's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

CME Group Payout Ratio History

DateCME Group Payout ratio
2028e105.83 %
2027e105.37 %
2026e104.8 %
2025e107.32 %
2024e103.98 %
2023103.11 %
2022114.86 %
202193.96 %
2020100.51 %
201993.06 %
201879.68 %
201751.42 %
2016196.47 %
2015132.79 %
2014115.82 %
2013150.68 %
2012114.52 %
201120.63 %
201032.17 %
200937.1 %
200879.01 %
200723.01 %
200621.72 %
200520.91 %
200416.25 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for CME Group.

CME Group latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20242.68 2.68  (-0.04 %)2024 Q3
6/30/20242.56 2.56  (0.05 %)2024 Q2
3/31/20242.48 2.5  (0.99 %)2024 Q1
12/31/20232.31 2.37  (2.81 %)2023 Q4
9/30/20232.24 2.25  (0.25 %)2023 Q3
6/30/20232.22 2.3  (3.47 %)2023 Q2
3/31/20232.4 2.42  (0.88 %)2023 Q1
12/31/20221.9 1.92  (1.05 %)2022 Q4
9/30/20221.96 1.98  (1.23 %)2022 Q3
6/30/20221.95 1.97  (0.82 %)2022 Q2
1
2
3
4
5
...
9

Eulerpool ESG Scorecard© for the CME Group stock

Eulerpool World ESG Rating (EESG©)

64/ 100

🌱 Environment

30

👫 Social

99

🏛️ Governance

63

Environment

Scope 1 - Direct Emissions
134
Scope 2 - Indirect emissions from purchased energy
19,574
Scope 3 - Indirect emissions within the value chain
145,739
Total CO₂ emissions
19,708
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees32
Percentage of women in management
Percentage of Asian employees23.7
Share of Asian management
Percentage of Hispanic/Latino employees6.3
Hispano/Latino Management share
Percentage of Black employees5.9
Black Management Share
Percentage of white employees54.7
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

CME Group shareholders

%
Name
Stocks
Change
Date
9.27950 % The Vanguard Group, Inc.33,414,543164,1686/30/2024
5.03069 % BlackRock Institutional Trust Company, N.A.18,115,009-310,9366/30/2024
4.44817 % State Street Global Advisors (US)16,017,402306,2856/30/2024
3.43209 % Capital World Investors12,358,609-825,8926/30/2024
2.82805 % Capital International Investors10,183,528-5,625,6476/30/2024
2.27178 % JP Morgan Asset Management8,180,468-1,914,4996/30/2024
2.26112 % Geode Capital Management, L.L.C.8,142,053197,2016/30/2024
1.44244 % Columbia Threadneedle Investments (US)5,194,065539,2386/30/2024
1.41148 % Parnassus Investments, LLC5,082,612-363,0836/30/2024
1.33689 % Norges Bank Investment Management (NBIM)4,814,013259,1246/30/2024
1
2
3
4
5
...
10

CME Group Executives and Management Board

Hon. Terrence Duffy(64)
CME Group Executive Chairman of the Board, Chief Executive Officer (since 1995)
Compensation 22.94 M
Ms. Julie Holzrichter(54)
CME Group Chief Operating Officer, Senior Managing Director - Global Operations and CME Clearing
Compensation 3.29 M
Mr. Sunil Cutinho(51)
CME Group Chief Information Officer
Compensation 3.29 M
Mr. Larry Gerdes(73)
CME Group Independent Director
Compensation 344,399
Mr. Dennis Suskind(80)
CME Group Independent Director
Compensation 335,566
1
2
3
4
5
...
7

CME Group Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Japan Exchange Group, Inc. Stock
Japan Exchange Group, Inc.
SupplierCustomer0,600,900,86
SupplierCustomer0,580,950,940,48-0,010,75
SupplierCustomer0,520,57-0,37-0,230,36
SupplierCustomer0,450,870,940,83-0,030,71
SupplierCustomer0,440,890,960,810,650,86
SupplierCustomer0,31-0,85-0,06-0,140,20-0,09
SupplierCustomer0,290,90-0,14-0,150,200,72
SupplierCustomer0,180,760,880,55-0,35-0,44
SupplierCustomer-0,100,820,420,13-0,33-0,65
SupplierCustomer-0,110,790,950,42-0,030,60
1

Most common questions regarding CME Group

What values and corporate philosophy does CME Group represent?

CME Group Inc represents a steadfast commitment to integrity, innovation, and collaboration. Known as the leading derivatives marketplace, CME Group fosters a transparent and trusted environment for global financial markets. With a focus on providing reliable risk management solutions, CME Group empowers market participants to manage their portfolios efficiently. The company's philosophy revolves around driving market efficiency while ensuring fairness and equal access to all participants. CME Group's dedication to customer-centric solutions, technological advancements, and industry-leading expertise solidifies its position as a trusted partner in the ever-evolving financial landscape.

In which countries and regions is CME Group primarily present?

CME Group Inc is primarily present in various countries and regions worldwide. Its presence spans across the United States, with its headquarters in Chicago, Illinois. Additionally, CME Group has a significant presence in Europe, particularly in London and Belfast. The company also maintains offices and operations in Asia, specifically in Singapore and Tokyo. With its global reach, CME Group Inc serves as a leading financial exchange, connecting market participants from around the world and offering a diverse range of derivatives and futures products.

What significant milestones has the company CME Group achieved?

CME Group Inc, a renowned financial market corporation, has achieved significant milestones throughout its existence. The company has demonstrated remarkable growth and success, becoming the world's largest futures exchange operator. CME Group has expanded its offerings by introducing innovative products and technology, continually enhancing market efficiency and providing reliable risk management solutions to market participants. With its merger in 2007, CME Group created a global powerhouse, enabling seamless trading and clearing across multiple asset classes. CME Group's commitment to driving industry advancement has resulted in numerous accolades, solidifying its reputation as a leader in the global financial industry.

What is the history and background of the company CME Group?

CME Group Inc, founded in 1898 as Chicago Butter and Egg Board, has a rich history and a prominent position in the financial industry. Over the years, the company expanded its offerings and acquired several other exchanges, including the Chicago Mercantile Exchange and the New York Mercantile Exchange. Today, CME Group is the world's leading and most diverse derivatives marketplace, facilitating trading across various asset classes, including futures, options, and derivatives. With a strong focus on innovation and technology, CME Group continues to provide global customers with reliable and transparent markets, enabling them to manage risk and achieve their financial goals efficiently.

Who are the main competitors of CME Group in the market?

CME Group Inc faces competition from various players in the market. Some of the main competitors include Intercontinental Exchange (ICE), Nasdaq, and Chicago Board Options Exchange (CBOE). These competitors also operate in the global derivatives exchange and clearing industry, offering similar products and services. However, CME Group Inc's leading position, diverse product range, and extensive market reach enable it to maintain a competitive edge in the industry.

In which industries is CME Group primarily active?

CME Group Inc is primarily active in the financial industry.

What is the business model of CME Group?

The business model of CME Group Inc is centered around operating a global marketplace for derivatives, options, and futures contracts. As the world's largest futures exchange, CME Group facilitates trading across multiple asset classes, including agricultural products, energy, metals, interest rates, and equity indexes. It provides a platform for market participants to manage price risks, access liquidity, and enhance portfolio diversification. CME Group's business model relies on offering innovative trading products, robust risk management tools, and technologically advanced trading platforms to serve the needs of a diverse range of market participants, such as institutional investors, corporations, and individual traders.

What is the P/E ratio of CME Group 2024?

The CME Group P/E ratio is 21.34.

What is the P/S ratio of CME Group 2024?

The CME Group P/S ratio is 12.83.

What is the Quality Investing of CME Group?

The Quality Investing for CME Group is 8/10.

What is the revenue of CME Group 2024?

The expected CME Group revenue is 6.18 B USD.

How high is the profit of CME Group 2024?

The expected CME Group profit is 3.71 B USD.

What is the business model of CME Group

The CME Group Inc is one of the world's leading companies in the derivatives exchange sector. Its business model is based on trading futures and options on commodities, stock indices, interest rates, and currencies on the exchanges of Chicago and New York. The CME Group offers a wide range of financial products that enable its customers to hedge risks or speculate on the price movements of assets. The products offered include futures contracts, options contracts, swap contracts, and other complex derivative instruments. The CME Group is divided into four business segments: first, there is the agricultural commodities segment, where futures on corn, wheat, soybeans, and other agricultural products are traded, for example. The energy segment includes futures and options on natural gas, oil, and electricity. The metals and minerals segment offers futures and options on gold, silver, copper, and other precious metals. Finally, there is the interest rates and currencies segment, where futures and options on various currencies and interest rates are traded. In addition to offering financial products, the CME Group also provides various services, such as data and information services and clearing services. In this context, it also operates clearing houses that settle transactions between customers, clear them in real-time, and thereby minimize risk for all parties involved. To serve its customers in the best possible way, the CME Group has also developed several platforms. The Global Command Center (GCC) is one of the most advanced trading platforms in the world and offers an optimal data- and information-based trading environment while also providing complex analysis functions to its customers. In recent years, the CME Group has become a leading provider in the derivatives exchange sector. Its innovative technology and efficient transaction processing, as well as the high quality of its products and services, have contributed to an increase in trading volumes. Today, leading financial institutions, hedge funds, companies, and individual investors trade at the CME Group, which repeatedly sets standards through its market-dominating position.

What is the CME Group dividend?

CME Group pays a dividend of 8.5 USD distributed over 4 payouts per year.

How often does CME Group pay dividends?

CME Group pays out a dividend 4 times a year.

What is the CME Group ISIN?

The ISIN of CME Group is US12572Q1058.

What is the CME Group WKN?

The WKN of CME Group is A0MW32.

What is the CME Group ticker?

The ticker of CME Group is CME.

How much dividend does CME Group pay?

Over the past 12 months, CME Group paid a dividend of 9.65 USD . This corresponds to a dividend yield of about 4.38 %. For the coming 12 months, CME Group is expected to pay a dividend of 9.58 USD.

What is the dividend yield of CME Group?

The current dividend yield of CME Group is 4.38 %.

When does CME Group pay dividends?

CME Group pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of CME Group?

CME Group paid dividends every year for the past 25 years.

What is the dividend of CME Group?

For the upcoming 12 months, dividends amounting to 9.58 USD are expected. This corresponds to a dividend yield of 4.25 %.

In which sector is CME Group located?

CME Group is assigned to the 'Finance' sector.

Wann musste ich die Aktien von CME Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CME Group from 9/25/2024 amounting to 1.15 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did CME Group pay the last dividend?

The last dividend was paid out on 9/25/2024.

What was the dividend of CME Group in the year 2023?

In the year 2023, CME Group distributed 8.5 USD as dividends.

In which currency does CME Group pay out the dividend?

The dividends of CME Group are distributed in USD.

All fundamentals about CME Group

Our stock analysis for CME Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CME Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.